Literature DB >> 13510721

Serum glutamic oxalacetic transaminase in diseases of the liver and biliary tract.

S MADSEN, N U BANG, K IVERSEN.   

Abstract

Entities:  

Keywords:  BILIARY TRACT/diseases; LIVER DISEASES/blood in; TRANSAMINASES/in blood

Mesh：

Substances：

Year:  1958        PMID： 13510721      PMCID： PMC2027921          DOI： 10.1136/bmj.1.5070.543

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Serum transaminase levels in experimental myocardial infarction.

Authors:  C M AGRESS; H I JACOBS; H F GLASSNER; M A LEDERER; W G CLARK; F WROBLEWSKI; A KARMEN; J S LADUE
Journal:  Circulation       Date:  1955-05       Impact factor: 29.690

2.  Serum glutamic oxalacetic transaminase as an index of hepatocellular integrity.

Authors:  D W MOLANDER; F WROBLEWSKI; J S LADUE
Journal:  J Lab Clin Med       Date:  1955-12

3.  A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum.

Authors:  A KARMEN
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

4.  Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction.

Authors:  J S LADUE; F WROBLEWSKI; A KARMEN
Journal:  Science       Date:  1954-09-24       Impact factor: 47.728
  4 in total
  2 in total

1.  Serum transaminase levels in liver disease.

Authors:  L HENRY
Journal:  J Clin Pathol       Date:  1959-03       Impact factor: 3.411

2.  Serum glutamic oxalacetic transaminase in acute myocardial infarction.

Authors:  H A DEWAR; N R ROWELL; A J SMITH
Journal:  Br Med J       Date:  1958-11-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.